⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions USA - English USA - English
prnewswire.com
LLY
FDA approves Lilly's Foundayo™ (orforglipron), the only GLP-1 pill for weight loss that can be taken any time of day without food or water restrictions
prnewswire.com
LLY
AAVantgarde appoints Philip Lao as Senior Vice President of Business Development
globenewswire.com
LLY
Gemcitabine Hydrochloride Market Report 2026-2030 & 2035 Featuring Strategic Analysis of Fresenius Kabi, Eli Lilly and Company, Teva Pharma, Intas Pharma, Mylan and More
globenewswire.com
LLY
AZN
Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA
businesswire.com
CNTA
LLY
Nxera Pharma’s Partner Centessa Pharmaceuticals to be Acquired by Lilly
globenewswire.com
LLY
CNTA
Form 8-K
sec.gov
CNTA
LLY
PatentVest Releases New Pulse Report on the $19 Billion Amylin Drug Race Transforming Obesity Treatment
globenewswire.com
NVO
LLY
PFE
ABBV
Autoinjectors Market worth $300.46 billion by 2031 | MarketsandMarkets™
prnewswire.com
BDX
ABBV
LLY
Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
prnewswire.com
CNTA
LLY